City State Bank Boosts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

City State Bank lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 228 shares of the medical equipment provider’s stock after buying an additional 30 shares during the quarter. City State Bank’s holdings in Intuitive Surgical were worth $101,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Baystate Wealth Management LLC boosted its holdings in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the period. Creekmur Asset Management LLC boosted its stake in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the period. MCF Advisors LLC grew its holdings in Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 40 shares in the last quarter. Able Wealth Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Finally, Delos Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 57 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on ISRG shares. Evercore ISI reduced their price objective on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research note on Friday, July 19th. Barclays upped their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Morgan Stanley lifted their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Robert W. Baird raised their price target on Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a report on Friday, July 19th. Finally, Piper Sandler boosted their price objective on Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $442.30.

Intuitive Surgical Trading Up 2.2 %

ISRG stock traded up $9.66 during midday trading on Tuesday, hitting $447.66. The company had a trading volume of 1,662,729 shares, compared to its average volume of 1,573,488. The stock has a market cap of $158.79 billion, a price-to-earnings ratio of 80.81, a PEG ratio of 4.97 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $468.78. The stock’s 50 day moving average price is $432.79 and its 200 day moving average price is $402.15.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.18 earnings per share. Analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Insider Activity

In other Intuitive Surgical news, Director Craig H. Barratt sold 2,496 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $402.89, for a total value of $1,005,613.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Robert Desantis sold 284 shares of Intuitive Surgical stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $110,521.44. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,142,714.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Craig H. Barratt sold 2,496 shares of the company’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 16,005 shares of company stock valued at $6,894,422. Insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.